Credo Diagnostics is proud to be one of the Top 50 Healthcare Startups in Singapore!
Credo Diagnostics is proud to be on the list of “Top 50 Healthcare Startups in Singapore” published by StartupLanes. We vow to accelerate the molecular test and provide it at an affordable cost. Being on the list of Top 50 Healthcare Startups is a great reward to our efforts and our pursuit to the mission […]
Credo VitaPCR™ SARS-CoV-2 RNA detection Assay can correctly detect the new Omicron strain B.1.1.529 BA.1 and its sublineage BA.2 (stealth version)
In response to the new Omicron variant (also known as B.1.1.529), we, Credo Diagnostics Biomedical Pte Ltd, have performed the BLASTn analysis (with the oligonucleotide primers and probes of the assays involving SARS-CoV-2 detection) against the sequences listed in GISAID on December 17th, 2021. According to our analysis, we confirm that our SARS-CoV-2 RNA detection […]
